Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-26T21:50:40.800Z Has data issue: false hasContentIssue false

SG-APSIC1100: Healthcare-associated infections in COVID-19 patients in Vietnam: Are we able to respond better?

Published online by Cambridge University Press:  16 March 2023

Thu Truong Anh
Affiliation:
Bach Mai Hospital, Hanoi, Vietnam
Dao Xuan Co
Affiliation:
Bach Mai Hospital, Hanoi, Vietnam
Do Ngoc Son
Affiliation:
Bach Mai Hospital, Hanoi, Vietnam
Pham The Thach
Affiliation:
Bach Mai Hospital, Hanoi, Vietnam
Luong Quoc Chinh
Affiliation:
Bach Mai Hospital, Hanoi, Vietnam
Huynh Xuan Nghiem
Affiliation:
Hung Vuong Hospital, Hochiminh, Vietnam
Nguyen Dai Vinh
Affiliation:
Hoa Vang District Medical Center, Danang, Vietnam
Truong Thai Phuong
Affiliation:
Bach Mai Hospital, Hanoi, Vietnam
Pham Hong Nhung
Affiliation:
Bach Mai Hospital, Hanoi, Vietnam
Le Duc Nhan
Affiliation:
Da Nang Hospital, Danang, Vietnam
Tran Thi Dung
Affiliation:
Bach Mai Hospital, Hanoi, Vietnam
Tran Thi Nga
Affiliation:
Bach Mai Hospital, Hanoi, Vietnam
Nguyen Quang Tuan
Affiliation:
Bach Mai Hospital, Hanoi, Vietnam

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Objectives: Studies have revealed that a relatively high incidence of severe infection and mortality in COVID-19 patients is attributed to healthcare-associated infections (HAIs). We implemented a study in 2 field hospitals dedicated to COVID-19 treatment in Da Nang, Vietnam (July–August 2020), and Ho Chi Minh City, Vietnam (August–October 2021), to identify pathogens, risk factors, and outcomes associated with HAIs. Methods: We applied a prospective study tool to estimate HAI incidence among 1,454 patients. HAIs are diagnosed and ascertained using surveillance criteria established by the US Centers for Disease Control and Prevention. All patients hospitalized for COVID-19 for at least 2 days were enrolled in this assessment of HAI risks, pathogens, and outcomes. Results: Among 1,454 sampled patients, 391 patients had 423 HAIs (27.1%). The highest proportion occurred in ICUs, with 422 HAI patients (34.1%). Pneumonia (n = 331, 78.3%) and bloodstream infections (n = 55, 13.1%) were the most common HAIs. Multidrug-resistant (MDR) bacteria, such as Klebsiella pneumonia (27.9%) and Acinetobacter baumannii (25.3%), were the most commonly isolated organisms. Ventilators and central venous catheters were independently associated with HAIs. Regarding the mortality rates, 55% of deaths occurred in intensive care units. Patients with HAIs (70.3%) were twice as likely to die compared to patients without HAIs (38.8%). HAIs leading to septic shock caused almost triple mortality (n = 58, 90.6%) compared with non-HAI patients (n = 412, 38.8%). HAIs prolonged hospital stay: 24.7 days for patients with HAIs and 19.1 days for patients without HAIs (P < .001). Conclusions: Patients with COVID-19–related critical illnesses are at high risk of HAIs from multidrug-resistant (MDR) bacteria. HAIs prolong hospitalization, whereas HAIs with septic shock almost tripled mortality. Guidelines and procedures to prevent and control HAIs caused by MDR bacteria as well as training and monitoring on aseptic-compliant techniques during invasive clinical procedures are needed.

Type
Healthcare-Associated Infection (HAI) Surveillance
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America